Connective tissue diseases: Targeting type I interferon in systemic lupus erythematosus
- PMID: 27225301
- DOI: 10.1038/nrrheum.2016.83
Connective tissue diseases: Targeting type I interferon in systemic lupus erythematosus
Comment on
-
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.Ann Rheum Dis. 2016 Nov;75(11):1909-1916. doi: 10.1136/annrheumdis-2015-208562. Epub 2016 Mar 23. Ann Rheum Dis. 2016. PMID: 27009916 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical